BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6009215)

  • 1. [Basic studies on the cause of urolithiasis. I. Stone producing substances and experimental stone formation with administration of drugs].
    Matsuo M
    Hinyokika Kiyo; 1966 Sep; 12(9):847-59. PubMed ID: 6009215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney ultrastructure in experimental lithiasis and nephrocalcinosis].
    Blagodarov VN
    Biull Eksp Biol Med; 1976; 81(4):494-6. PubMed ID: 1084176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion.
    Parfitt AM
    Arch Intern Med; 1969 Dec; 124(6):736-40. PubMed ID: 5353483
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypervitaminosis D.--A case report.
    Taylor FE
    Med Times; 1966 Nov; 94(11):1275-9. PubMed ID: 5922345
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.
    Grujic D; Salido EC; Shenoy BC; Langman CB; McGrath ME; Patel RJ; Rashid A; Mandapati S; Jung CW; Margolin AL
    Am J Nephrol; 2009; 29(2):86-93. PubMed ID: 18698135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy after acute hypervitaminosis-D (an experimental study).
    Arya SN; Das GC
    J Indian Med Assoc; 1973 Dec; 61(12):503-6. PubMed ID: 4791939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urolithiasis during treatment of carbonic anhydrase inhibitors].
    Kondo T; Sakaue E; Koyama S; Matsuo M; Takahashi Y
    Nihon Ganka Kiyo; 1968 Apr; 19(4):576-84. PubMed ID: 5749047
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: an underrecognized cause of psychiatric symptoms.
    Stoudemire A; Houpt JL
    Psychiatr Med; 1983 Sep; 1(3):353-5. PubMed ID: 6599857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does vitamin E protect against experimental lithiasis?].
    Sakly A; Achour A; Zouaghi H
    Ann Urol (Paris); 1994; 28(5):265-7. PubMed ID: 7825984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrocalcinosis, primary hyperoxaluria, hypervitaminosis D. Relation of 2 cases].
    Socquet Y; Brenez J; Crabbe J
    Acta Urol Belg; 1967 Oct; 35(4):545-72. PubMed ID: 5618332
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrocalcinosis formation by soy isoflavones in male rats.
    Satoh T; Yamakoshi J; Saito M; Izumi T; Matsuyama A; Kikuchi M; Yamaguchi T
    J Agric Food Chem; 2006 Jul; 54(15):5659-63. PubMed ID: 16848560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic studies on the cause of urolithiasis. 3. Role of urinary citrate in urolithiasis.
    Matsuo M
    Hinyokika Kiyo; 1966 Sep; 12(9):869-80 concl. PubMed ID: 6009217
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of new concepts in renal stone research.
    Cao LC; Boevé ER; de Bruijn WC; Robertson WG; Schröder FH
    Scanning Microsc; 1993 Sep; 7(3):1049-64; discussion 1064-5. PubMed ID: 8146606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic studies on the cause of urolithiasis. II. Experimental foreign body stone formation].
    Matsuo M
    Hinyokika Kiyo; 1966 Sep; 12(9):861-8. PubMed ID: 6009216
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association of the nephrotic syndrome and histopathological nephrocalcinosis].
    Rodríguez W; Wilhelm V; Reyes M; Pomeroy J
    Rev Chil Pediatr; 1979; 50(1):62-6. PubMed ID: 504750
    [No Abstract]   [Full Text] [Related]  

  • 17. Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.
    Doneray H; Ozkan B; Caner I; Ozkan A; Karakelleoglu C
    Clin Toxicol (Phila); 2008 Apr; 46(4):300-2. PubMed ID: 18363123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of uric acid on sodium oxalate-induced urolithiasis in rats--biochemical and histological evidences.
    Poonkuzhali B; Saraswathi CP; Rajalakshmi K
    Indian J Exp Biol; 1994 Jan; 32(1):20-4. PubMed ID: 8045600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced urinary calculi in 1999].
    Daudon M
    Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.